A study on 479 pre- and postmenopausal women reported that a combination of CA-125 and IOTA-SR models had better diagnostic value in differentiating malignant from benign ovarian tumors with AUCs of 0.94 and 0.98, respectively (33). Here, MUC16 is linked to ovarian benign neoplasm.